Harbin Honor Pharmaceutical Co., Ltd. Stock Code: 002437 Stock Abbreviation: Honor Pharmaceutical Announcement No.: 2026-022
Announcement on Special Explanation Regarding No Profit Distribution for 2025
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
On April 24, 2026, Harbin Honor Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") deliberated and passed the "Proposal on the 2025 Profit Distribution Plan" at the Ninth Meeting of the Seventh Board of Directors. This proposal still needs to be approved by the Company's 2025 Annual Shareholders' Meeting. The details are as follows:
I. Deliberation Procedures
On April 24, 2026, the Ninth Meeting of the Seventh Board of Directors of the Company deliberated and passed the "Proposal on the 2025 Profit Distribution Plan." The voting result was: 8 votes in favor, 0 votes against, and 0 abstentions.
The Board of Directors believes that this profit distribution plan complies with the relevant provisions on profit distribution in the "Company's Articles of Association" and the "Three-Year (2023-2025) Shareholder Return Plan," and is legal, compliant, and reasonable. It is agreed to submit this profit distribution plan to the Company's 2025 Annual Shareholders' Meeting for deliberation.
II. Basic Situation of the Profit Distribution Plan